These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30389105)

  • 1. Validation of the 2018 FIGO cervical cancer staging system.
    Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
    Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
    Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
    McComas KN; Torgeson AM; Ager BJ; Hellekson C; Burt LM; Maurer KA; Werner TL; Gaffney DK
    Gynecol Oncol; 2020 Jan; 156(1):85-92. PubMed ID: 31744640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Maeda M; Mabuchi S; Sakata M; Deguchi S; Kakubari R; Matsuzaki S; Hisa T; Kamiura S
    Jpn J Clin Oncol; 2024 Feb; 54(2):146-152. PubMed ID: 37935434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Kim J; Cho Y; Kim N; Chung SY; Kim JW; Lee IJ; Kim YB
    Gynecol Oncol; 2021 Mar; 160(3):735-741. PubMed ID: 33358037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.
    Liu X; Wang W; Hu K; Zhang F; Hou X; Yan J; Meng Q; Zhou Z; Miao Z; Guan H; Ma J; Shen J; Zhen H; Wang W
    Sci Rep; 2020 Jan; 10(1):362. PubMed ID: 31941966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.
    Long X; He M; Yang L; Zou D; Wang D; Chen Y; Zhou Q
    Clin Med Insights Oncol; 2023; 17():11795549221146652. PubMed ID: 36726607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Shin W; Ham TY; Park YR; Lim MC; Won YJ
    Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
    Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
    Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Zhang Y; Wang C; Zhao Z; Cheng L; Xu S; Xie P; Xie L; Zhang S
    Int J Gynaecol Obstet; 2024 Jun; 165(3):959-968. PubMed ID: 37950594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage migration and survival outcomes in patients with cervical cancer at Stage IIIC according to the 2018 FIGO staging system: a systematic review and meta-analysis.
    Han L; Chen Y; Zheng A; Tan X; Chen H
    Front Oncol; 2024; 14():1460543. PubMed ID: 39411135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Kim SI; Lee M; Lee S; Suh DH; Kim HS; Kim K; Chung HH; No JH; Kim JW; Park NH; Song YS; Kim YB
    Gynecol Oncol; 2019 Oct; 155(1):75-82. PubMed ID: 31383569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
    Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
    Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
    J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?
    Cooke EW; Pappas L; Gaffney DK
    Cancer; 2011 Sep; 117(18):4231-7. PubMed ID: 21387282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.